Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Nausea × Taxes × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 59 Breast Neoplasms 56 Carcinoma, Non-Small-Cell Lung 37 Triple Negative Breast Neoplasms 23 Ovarian Neoplasms 20 Fallopian Tube Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 16 Lung Neoplasms 13 Stomach Neoplasms 11 Neoplasm Metastasis 10 Breast Neoplasms, Male 9 Inflammatory Breast Neoplasms 7 Esophageal Neoplasms 7 Cholangiocarcinoma 7 Neoplasms 6 Melanoma 6 Endometrial Neoplasms 6 Gallbladder Neoplasms 5 Carcinoma, Ovarian Epithelial 5 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4 Recurrence 4 Prostatic Neoplasms 4 Pancreatic Adenocarcinoma 4 Esophageal Squamous Cell Carcinoma 4 Carcinoma, Transitional Cell 4 Biliary Tract Neoplasms 4 Adenocarcinoma Of Esophagus 4 Adenocarcinoma 4 Oropharyngeal Neoplasms 3

Interventions

Dexamethasone 25 Aprepitant 23 Palonosetron 18 Ondansetron 18 Calcium Dobesilate 13 Olanzapine 12 Granisetron 11 Therapeutics 7 fosaprepitant 6 Doxorubicin 6 Cyclophosphamide 6 dexamethasone acetate 5 netupitant 4 Vincristine 4 dolasetron 3 Tropisetron 3 Prochlorperazine 3 Metoclopramide 3 Lorazepam 3 Dronabinol 3 Acupressure 3 peppermint oil 2 netupitant, palosentron drug combination 2 ginger extract 2 dexamethasone 21-phosphate 2 Surveys and Questionnaires 2 Sugars 2 Rituximab 2 Radiotherapy 2 Psychiatric Rehabilitation 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06017284 2023-11-24

PTCA199-5

Fudan University

Phase 3 Recruiting

Gastrointestinal

Nausea, Pancreatic Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon ⚡